Prof. Asmaa Al-Thani
Professor of Virology at the Biomedical Science Department and Dean of the College of Health Sciences at Qatar University
Dr. Asmaa Al-Thani is a Professor of Virology at the Biomedical Science Department and Dean of the College of Health Sciences at Qatar University. Dr. Al-Thani obtained her PhD from the University of London in the United Kingdom.
Dr. Al-Thani is also Adjunct Assistant Professor in the Department of Microbiology and Immunology at Weill Cornell Medical College in Qatar, Vice Chairperson of the Qatar Biobank Board, nominate to be Chair of National Genome Qatar Committee, and Director of Biomedical Research Centre at Qatar University.
Dr. Al-Thani has numerous published articles in her field of expertise, including 36 published papers in peer-reviewed international journals. She has also obtained several research grants, including seven Qatar University grants, 13 UREP grants and four NPRP grants. She was the recipient of the First Prize of Sheikh Hamad Bin Rashid for Culture and Sciences for research in December 2006, and was awarded a prize from the Al-Jasra Cultural Club-Qatar for student research. She works as reviewer for several scientific journals and conferences, and is a member in the American Society for Microbiology.
Dr. Ajayeb Al Nabet
Chairperson, Department of Laboratory Medicine & Pathology,(DLMP) Hamad Medical Corporation
Dr Ajayeb Al-Nabet obtained her PhD from the Royal Postgraduate Medical School, London, UK.
In 2009, Dr Al-Nabet was appointed as Chairperson of the DLMP, incorporating 29 sections with core laboratories in 7 hospitals. The DLMP is staffed by approximately 770 medical, technical, support and nursing personnel. In 2016, the DLMP achieved the College of American Pathologists (CAP) re-accreditation of clinical and anatomic laboratories across the State of Qatar.
Dr. Ajayeb Al-Nabet is the Chairperson for the National Qatar BioBank Committee and Member of the Qatar Genome Committee and Qatar Biobank Board.
Dr Al-Nabet held an academic appointment at Qatar University in Biomedical Sciences Program 1997-2006, is involved in research programs supported by HMC and Qatar Foundation and has publications in international peer review journals. Her memberships include Ministry of Public Health, Viral Hepatitis Advisory Committee, National Laboratory Integration and Standardization Strategy Project.
Professor Akin Abayomi
Chief Pathologist and Head of the Division of Haematology - University of Stellenbosch, South Africa
Professor Akin Abayomi is the Chief Pathologist and Head of the Division of Haematology at the University of Stellenbosch, South Africa (www.sun.ac.za/haema). He studied at the Royal Medical College of St Bartholomew’s Hospital at the University of London where he attained his first graduate degree in Medicine. He went on to specialize in Internal Medicine and Haematology, obtaining fellowships from the Royal College of Medicine and the Royal College of Pathologists of the United Kingdom as well as the College of Medicine of South Africa. Professor Abayomi has worked in several countries around the world in both Internal Medicine and Haematology. His focus has mainly been on the complications of HIV and the development of laboratory and clinical capacity to rise to the challenge of the HIV epidemic in the developing world and Africa. He is the PI to the Tygerberg Lymphomas Study Group and the Global Emerging Pathogens Treatment Consortium and a member of the H3Africa and B3Africa consortia. Akin Abayomi is the Director of the NHLS Stellenbosch Cape Town Biobank. He is also interested in the impact of climate change on health and the footprint of humanity on ecological integrity and human-wildlife interaction.
Professor Mostafa Abolfotouh
MD, PhD, FASHA (USA) - Head of Biobanking Section at King Abdullah International Medical Research Center (KAIMRC), and a professor at King Saud bin-Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard, Riyadh, Saudi Arabia.
Mostafa Abolfotouh is the Head of Biobanking Section at King Abdullah International Medical Research Center (KAIMRC), and a professor at King Saud bin-Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard, Riyadh, Saudi Arabia. He is a professor of Family Health in Alexandria University, Egypt and is a WHO/EMR Regional expert in Adolescent & School health. He is the Chief Editor of some regional & international journals such as; Journal of Public Health & Epidemiology and Journal of Continuous education & professional development and Saudi Journal of Obesity. He has more than 200 research articles published in national and international journals. He authored some books in Public Health, school health and paediatrics, all are available on Amazon web page. For contact: firstname.lastname@example.org.
Ph.D. President - Personalized Medicine Coalition - Washington DC - USA
Edward Abrahams, Ph.D., is the president of the Personalized Medicine Coalition (PMC). Representing innovators, scientists, patients, providers and payers, PMC promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. It has grown from its original 18 founding members in 2004 to more than 225 today.
Previously, Dr Abrahams was the executive director of the Pennsylvania Biotechnology Association, where he spearheaded the successful effort that led to the Commonwealth of Pennsylvania's investment of $200 million to commercialize biotechnology in the state. Earlier, he had been assistant vice president for federal relations at the University of Pennsylvania and held a senior administrative position at Brown University.
Dr Abrahams worked for seven years for the U.S. Congress, including as a legislative assistant to Senator Lloyd Bentsen, an economist for the Joint Economic Committee under the chairmanship of Representative Lee Hamilton, and as a AAAS Congressional Fellow for Representative Edward J. Markey.
The author of numerous essays, Dr Abrahams serves on the editorial board of Personalized Medicine and has taught history and public policy at Brown University and the University of Pennsylvania.
Dr Nahla Maher Afifi
Acting Director of Qatar Biobank
Dr Nahla Maher Afifi earned her MBBCh with honours from Ain Shams University, Egypt. She received her Master of Anatomy & Embryology, and a Diploma of Gynaecology and Obstetrics from the same University.
She received her Ph.D. of Anatomy & Embryology in 1996 from Ain Shams University under a joint supervision with University of Medicine and Dentistry, New Jersey, USA. Dr Afifi started her academic career as a Medical Researcher in the Department of Pharmacology and Toxicology, University of Medicine and Dentistry of New Jersey. She then served as Assistant Professor of Anatomy and Embryology at Ain Shams University, and Dubai Medical College for Girls, UAE. Dr Afifi joined Qatar University's Biomedical Sciences Program in 1999 and was promoted to Associate Professor of Anatomy and Embryology and to Full Professor on 2007.
She was assigned as a Head of Dept. of Health Sciences from 2007-2009. In December 2013 she joined QF. She is the Education and Scientific Manager/ Acting Director in Qatar Biobank. Dr Nahla Afifi has numerous published researches in her field of expertise. She is a member in several International societies AAA, ASIP, ISBER & ESBB
Marianna J. Bledsoe
MA - Chair, Science Policy Committee, International Society for Biological and Environmental Repositories - Deputy Editor, Biopreservation and Biobanking
Marianna is a consultant on ethical, legal, social, and policy issues related to human specimen research and Associate Editor for Biopreservation and Biobanking. She managed biobanks for more than 15 years at the National Institutes of Health (NIH) and the Department of Veterans Affairs. In the NIH Office of the Director, she played a major role developing national and international policies related to biobanking and clinical research. She was president of the International Society for Biological and Environmental Repositories (ISBER) in 2007. She chairs the ISBER Science Policy Committee and is a member of the ISBER ISO TC 276 Taskforce.
Prof. Ida Biunno
Senior Researcher at Institute for Genetic and Biomedical Research of the National Research Council (IRGB-CNR), Milano- Italy
Prof. Biunno is a senior Researcher at Institute for Genetic and Biomedical Research of the National Research Council (IRGB-CNR), Milano- Italy were she spent more than 30 years.
The main scientific activities are:
- the use of epigenetic/epigenomic modifications to re-program somatic cells into insulin producing cells;
- analyze the biochemical function of the cell quality control mechanisms (ERAD/UPR) in a variety of cellular physiological and pathological conditions including human cancer stem cells;
- biobanking of highly controlled pluripotent human stem cells
Prof. Biunno has Bachelor Degree in Biology and Psychology from Temple University, PhD in Biochemistry from the University of Pennsylvania, Philadelphia-PA (USA) and Doctoral Degree in Molecular Biology from the University of Milan-Italy.
Prof. Andrew Brooks
Chief Operating Officer of RUCDR Infinite Biologics and an Associate Professor of Genetics at Rutgers University - Rutgers - NJ - USA
Dr Brooks is the Chief Operating Officer of RUCDR Infinite Biologics and an Associate Professor of Genetics at Rutgers University. He is also one of the founding members of the Bioprocessing Solutions Alliance and serves as the Chief Scientific Officer of Brooks Life Sciences. Dr Brooks is a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. Dr Brooks is a well-recognized genomicist and has been involved in the development global biobanking initiatives and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses as it pertains to precision and personalize medicine.
Dr. Dianne Chadwick
PhD - Manager, University Health Network BioBank, Toronto, Canada
Dr. Chadwick is Manager of the Biobank at University Health Network (UHN). Previously, she received her PhD in Medical Biophysics from the University of Toronto, and completed a fellowship in Clinical Laboratory Genetics.
Dr. Chadwick has led the UHN Biobank for more than 5 years. She has played an active role in the growth and transformation of the UHN Biobank into an institutional resource for high-impact research in oncology, cardiovascular disease, multi-organ transplant and infectious disease. Her research interest is focused on quality assurance in BioBanking. She has co-authored several high impact publications with UHN and other investigators, as well as a review on high-quality biobanking. She has presented at several conferences including US Canada Association of Pathology (USCAP), Leaders in BioBanking Congress and International Society of Biological and Environment Repositories (ISBER). She currently serves on the 2017 ISBER Program Committee as co-chair of the session on Liquid Specimens. Dr. Chadwick looks forward to sharing her biobanking experience at the Qatar conference.
Dr Abdelbaset Buhmeida
Professor & Senior Scientist Coordinator, Biobanking & Molecular Pathology Units, Biorepositories and Biospecimen & Cancer Genomics Research Programs, Centre of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, Jeddah, Saudi Arabia
Dr Buhmeida worked at University of Turku, Finland since 1997, when He started pursuing studies for his doctoral thesis in the research group “Cancer Prognostication” led by Prof. Yrjo Collan, at the Department of Pathology. His PhD Thesis was focused on the use of fine needle biopsies from prostate cancer and on methods applying static computerized DNA Cytometry and Morphometry in prostate cancer diagnosis and prognostication. He successfully defended his thesis in 2002. At the end of 2009, He has been appointed as a Docent in Experimental Oncology (Associate Professor) at the Medical Faculty, University of Turku, while He was joining the Centre of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University (KAU), and Jeddah, Saudi Arabia. Once He indulged in the CEGMR, He worked hard for the development of CEGMR in the field of biomedical cancer research, which resulted in the publication of several scientific papers in international peer reviewed journals, to be then assigned as coordinator of the Biobank, the main core facility in any comprehensive genomic medicine research center.
Additionally, He has been also in the task of chairing various service units at CEGMR such as the Immunohistochemistry Unit (IHCU) named later the Histopathology Unit (HPU), and the Bioimaging Unit (BIU). As a biobanker, He played a pivotal role in enhancement of biobank unit activity at CEGMR by bridging and strengthening the connection between Biobanks Unit and different surgeons and pathologists of collaborative hospitals in the region on daily bases. On 2014, He has been promoted by the Academic Council of KAU to the academic rank of Professor. Currently, He is deeply involved as a main coordinator in launching a biobank program for 5 years to be considered as the first initiative and working model towards the establishment of Saudi National Biobank in order to be the main supplier of high quality and fully annotated biospecimens for healthcare scientists to convert their hypothesis to a discovery.
Moreover, He is focusing on the role of different histological, clinical and biological markers in the evaluation of prognosis of Saudi cancer patients and the relation of these markers with clinical features by applying advanced Omics platforms such as NGS, digital PCR and Microarray technologies. He is helping in building Decision Support Systems by validating cut-off points of potential bio-molecular markers to establish validated applicable Prognostic Models which might be applied as criteria for classifying Saudi cancer patients into good and poor prognostic groups.
A particular aim is to promote future connections and cooperation among cancer institutions nationally, regionally and internationally. This would establish universally more applicable guidelines for helping individualized cancer prevention and treatment of cancer.
Dr. Hinda Daggag
Genetics Project Specialist at Imperial College London Diabetes Centre (ICLDC), Abu Dhabi - UAE
Dr Hinda Daggag is a Genetic Projects Specialist at Imperial College London Diabetes Centre (ICLDC), Abu Dhabi. She received her PhD in Genetics in 2009 from Melbourne University, Australia, with her thesis focusing on Disorders of Sexual Development. Soon after obtaining her PhD, Dr Hinda moved to Amman, Jordan where she was managing a Genetics Diagnostic Laboratory at the National Center for Diabetes, Endocrinology and Genetics (NCDEG). While at NCDEG, her research interests were related to Congenital Adrenal Hyperplasia (CAH) and Turner Syndrome. Furthermore, she devoted her time counseling patients affected by various genetic disorders.
In November 2012, Dr Hinda joined ICLDC Research Department where she is currently involved in a number of genetics projects and oversees the running of ICLDC Repository.
Ing. Pasquale De Blasio
ESBB Founder President and ISENET Managing Director - Milan - Italy
Pasquale De Blasio, is the founder of ESBB and Chief Operating Managing Director of ISENET (Integrated Systems Engineering srl (www.isenet.it) and President of ISENET-USA LLC (www.isenet-usa.com) which operates in the following fiends:
- Tissue Microarray Technology, with the design, manufacture and distribution world wide of the Galileo Tissue Microarray Instruments (http://www.isenet.it/index.php/eu/products/ck-family).
- Stem Cell Banking (including iPS). Service provider of Characterization, Quality Control, Cryopreservation and distribution of high quality and well characterized stem cells lines (http://www.isenet.it/index.php/eu/services/cytogenetic-services)
Ing. Pasquale De Blasio, is a well-recognized Biobanking expert working in the field since 2001. In. 2014 Ing. Pasquale De Blasio 2014 organized the first ISBER Biobanking International Meeting in Perugia Italy and in 2010 he was one of the promoter and founding president of the "European, Middle East and African Society for Biorepository and Biobanking (ESBB), which constitutes the largest Biobanking Society in Europe, Middle East and Africa.
Ing. Pasquale De Blasio was also the Founder and CEO of BioRep srl (www.biorep.it). The largest Private Biorepository in Italy, which hosts the world largest Huntington Disease Biosepcimens Collection.
Ing. Pasquale De Blasio is also a member of the Qatar Biobank Advisory Committee (http://www.qatarbiobank.org.qa/) and of the GET Consortium (Global Emerging Pathogens Treatment Consortium - http://www.getafrica.org/)
Pasquale De Blasio participate also in several European or National Research Projects in the field of Neurodegenerative Diseases with its Stem Cell Bank (including iPS) and in Tissue Banking Research.
Khawla S. Al-Kuraya
MD FCAP : Director, Research Centre at KFNCCCKing Faisal Specialist Hospital and Research Centre Khawla Al-Kuraya, a distinguished physician-scientist, is the Director of the Research Centre at King Fahad National Centre for Children’s Cancer, King Faisal Specialist Hospital and Research (KFSH) in Riyadh, Saudi Arabia.
After receiving her Medical Degree from King Saud University School of Medicine in Riyadh, Saudi Arabia, she completed her Residency and Fellowship in Pathology at Georgetown University Hospital in Washington D.C.
Dr Al-Kuraya is a leader in the field of genomic cancer research. She is widely respected as Translational Scientist whose work bridges the laboratory and clinical settings.
She has focused on identifying molecular signature of common Saudi tumors utilizing the recent technologies in the cancer genetic field.
Under Dr Al-Kuraya’s leadership, Research Centre at KFSH has become a member in International Cancer Genome Consortium (ICGC) which aims to identify the molecular abnormalities more than 50 types of cancers.
An author of over 100 original research articles, editorials, review articles and book chapters. Dr Al-Kuraya’s professional memberships include the American Association for Cancer Research, College of American Pathologist and the American Society of Human Genetics. She is also on the Executive Committee of ICGC. She also serves on numerous editorial boards.
Dr Al-Kuraya is first Saudi female recipient of the prestigious “First Rank King Abdulaziz Medal” for her pioneering initiatives in cancer research. In 2013, Dr Khawla Al-Kuraya was appointed by His Royal Highness King Abdullah Bin Abdul Aziz of Saudi Arabia as one of the first women to be a member of the Majlis Al Shura Council (Inter-Parliamentary Union) of the Kingdom of Saudi Arabia.
Dr. Susan J. Done
Associate Professor, Departments of Laboratory Medicine and Pathobiology and Medical Biophysics, Faculty of Medicine, University of Toronto
Susan J. Done completed her medical training at Cambridge University and then moved to Canada where she is currently an Associate Professor in the Departments of Laboratory Medicine and Pathobiology, and Medical Biophysics, in the Faculty of Medicine at the University of Toronto. She is a pathologist at the University Health Network (which includes Toronto General Hospital and the Princess Margeret Cancer Centre) and a member of the Campbell Family Institute for Breast Cancer Research. Her research is focussed on breast cancer intratumoural heterogeneity, circulating tumour markers and early events in invasion and metastasis.
Marianne K. Henderson
Senior Advisor for Division Resources, Division of Cancer Epidemiology and Genetics and Senior Advisor on Biobanking, Centre for Global Health of the U.S. NCI
Ms. Henderson is Senior supports large program and contract management; and infrastructure planning for molecular epidemiology. She is active in the International Society for Biological and Environmental Repositories (ISBER) (ISBER President 2011-12 and current Chair of the OAC). She is a member of the NIH PMI – CP Biobank working group; and SC member and E&T Chair of the IARC-led LMIC Biobank and Cohort Network (BCNet); Ms. Henderson is actively involved in large-scale biospecimen process improvements in operations, technology transfer, sustainability and repository automation.
Dr. Said Ismail
Qatar Genome Project Program Manager, Doha - Qatar
Dr Said Ismail is the Manager of the Qatar Genome project (QGP), which is one of the major national programs of its kind in the region. The project, currently in its pilot phase, differentiates itself from other disease-based research organisations in the region in that it is a population-based initiative using specimen and population samples gathered by Qatar Biobank. Dr Ismail, a Ph.D. graduate from the University of Oxford, has 20 years of experience in molecular biology and genetics with a research focus on the screening and characterisation of disease related mutations in the Arab population.
Professor Elio Riboli
Director School of Public Health, Professor of Cancer Epidemiology and Prevention, Imperial College London, London, UK
Professor Elio Riboli, is Director of the School of Public Health at Imperial College London. Professor Riboli has focussed his research on diet, nutrition, metabolism, cancer and chronic diseases. He leads the European Prospective Investigation into Cancer and Nutrition (EPIC) which is a large cohort of half a million participants. Professor Riboli has co-authored over 600 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology.
Prof. Mats Hasson
Professor of Biomedical Ethics and Director of the Centre for Research, Ethics & Bioethics (CRB) -UPPSALA University, Sweden
Professor Mats Hansson is Professor of Biomedical Ethics and Director of The Centre for Research Ethics & Bioethics (CRB) at Uppsala University. He received his first degree in Biology 1974 and then moved into Theology, Philosophy and Bioethics. He has led several multi-disciplinary projects in bioethics. The Centre is a multi-disciplinary unit awarded for international excellence with long experience of managing large international projects, currently leading research on biobanking, patient preferences and risk communication. This 28- person team of researchers is combined with social scientists, psychologists and risk communication experts as well as ethicists. For info see: www.crb.uu.se
Dr Carolyn M. Hutter
Program Director in the Division of Genomic Medicine at the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), Bethesda MD, USA
Carolyn Hutter is a Program Director in the Division of Genomic Medicine at the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH). She serves as the NHGRI team lead for The Cancer Genome Atlas (TCGA), and is on the NIH leadership team for the Clinical Sequencing Exploratory Research (CSER) the Clinical Genome Resource (ClinGen) the Genome Sequencing Program Centres for Common Disease Genomics (CCDG).and the Precision Medicine Initiative® All of US Research Program.
Prior to NIH, Dr Hutter was a Senior Staff scientist at the Fred Hutchinson Cancer Research Centre and a Lecturer (Part-Time) in the Epidemiology Department at the University of Washington School of Public Health. Her research focused on large-scale consortia studies of genome-wide association studies and gene-environment interactions in colorectal cancer and other complex diseases. Dr Hutter received her Sc.B. in Applied Mathematics-Biology with Honours from Brown University (1994), her M.S. in Genetics from Cornell University (1998), her M.S. in Biostatistics and her Ph.D. in Epidemiology from the University of Washington (2009; 2008). She received the Omenn Award for Academic Excellence, from the University of Washington School of Public Health and Community Medicine for her M.S. and Ph.D. work. Dr Hutter has received numerous awards, including the 2015 Samuel J. Hyman Service to America Medal “People’s Choice Award” award to Jean Claud Zenklusen, Carolyn Hutter, and The Cancer Genome Atlas Team. This award was in recognition of work that “Mapped thousands of gene sequences for more than thirty types of cancer, advancing precision medicine in the diagnosis, treatment and prevention of these deadly diseases”
Group Head Laboratory Services and Biobank Group - IARC Lyon France
Maimuna Mendy completed higher degree studies in Virology (PhD) at the University of London in 1994. In addition to her background in molecular virology and infectious disease and cancer, she has over 25 years’ experience in assembling and managing longitudinal cohort studies in Africa, managing biological resources and coordinating the biobank activities for several scientific projects. Dr Mendy has a broad background of capacity building in Low and Middle Income Country (LMIC) settings in the area of biobanking, laboratory and field research for epidemiological based studies and since 2010 she has expanded her interest in biobanking and now has a role in coordinating the Biobank and Cohort Building Network for LMIC (BCNet).
Maimuna Mendy joined IARC in 2010 as Head, Laboratory Services and Biobank Group. The Group is responsible for the management of over 5 million samples including one of the largest European Cohorts (EPIC) which has a total of 4 million samples. Dr Mendy successfully led the centralization of the IARC biobank which has brought together sample collections from individual studies on one platform and is managed centrally by a common database.
Dr Mendy has leveraged the experience gained from assembling and working with multiple cohort studies by providing technical and scientific expertise to LMIC biobanks including advising on issues related to quality, infrastructure, transnational access of biological samples and data and ethics. She continues to provide the relevant expertise in her role as co-applicant and PI for two EU-H2020 Grants; ADOPT-BBMRI-ERIC and B3Africa.
Dr Mendy’s memberships to international organizations include, being Vice President for AORTIC, Independent Expert Committee Member for the H3Africa Biorepository program, representing IARC as a member of the Assembly of Members and Scientific Committee for BBMRI-ERIC, member of ESBB and ISBER. She also serves as education and training committee member for ISBER and ESBB and on several other Scientific Advisory Boards.
Dr Manuel Morente
Spanish National Cancer Research Centre (CNIO) Spanish National Biobank Network coordinator, Madrid, Spain
- Twenty years of clinical expertise as surgical pathologist, with special activity in Haematopathology, and 15 years as professor at Alcala University (Madrid, Spain)
- Head of the Spanish National Cancer Research Centre biobank.
- Coordinator and main promoter of the Spanish National Tumor Bank Network (2000-2011).
- From 2010, coordinator of the Spanish National Biobank Network, a nationwide initiative with more than 50 associated institutions (www.redbiobancos.es).
- Active participant in International Scientific Societies and Working Groups in Biobanking including ESBB (president 2013-2014), ISBER (councilor from 2005 to 2008), BBMRI preliminary phase (Scientific Representative of Spanish Government, 2010-2013), BCNet-WHO-IARC initiative (Steering Committee, 2013-…), etc.
- Director of the University Master on Biobanking organized by The Catholic University of Valencia and Spanish National Biobank Network.
- Independent Ethics advisor in EU-7thFP and IMI projects, and member of several international Scientific Advisory Board in biobanking.
Prof. Peter Riegman
HEAD of Herasmus Tissue Bank - Herasmus University, Rotterdam NL.
Professor Peter Riegman is a Molecular Biologist heading the Erasmus MC Tissue Bank, where fresh frozen tissue and pathology archival FFPE materials for medical research under secondary use is available according to ISO 15189:2012 standards. He was involved in the European projects: Eurocan Platform (WP leader of Biobanks), BIOPOOL, SPIDIA, BBMRI, and Euro BoNeT and coordinated the Tuba Frost project 2003-2006. He was co-opted board member and chair of the OECI working group bio banking 2006-2010. In 2008 became ISBER president-elect, and 2009-2010 ISBER president, followed by past president until 2011. At the end of 2010 elected vice president in ESBB (ISBER chapter) to become president in 2011, when he also became section editor in the Editorial board of Bio preservation and Biobanking and member of the International Steering Committee of P3G. From 2012 he became UMC-coordinator for the pearl string initiative for Erasmus MC. That same year he joined through NEN the CEN/TC140WG3 and ISO/TC212WG4 to write sample technical standards, now implemented together with BBMRI-ERIC.
Dr. Runjan Chetty
GI/Pancreas Pathologist University Health Network Laboratory Medicine Program Professor, Department of Laboratory Medicine and Pathobiology University of Toronto
- MB, BCh, BaO, LRCP, LRCS- Royal College of Surgeons/National University, Ireland
- FFPath (College of Medicine, South Africa)
- FRCPA (Royal College of Pathologists of Australasia)
- FFPath (Royal College of Physicians, Ireland)
- FRCPath (Royal College of Pathologists, United Kingdom
- FRCPC (Royal College of Physicians and Surgeons of Canada)
- FCAP (College of American Pathologists)
- DPhil/PhD (St. John’s College, University of Oxford)
- Interim Program Medical Director and Pathologist in Chief, Laboratory Medicine Program, University Health Network, Professor of Pathology, University of Toronto.
- Director for External Partnerships
- Head of the UHN Biobank,
- Consultant GI/Pancreas, Soft tissue pathologist
- Director of Translational Pathology/Professor of Pathology and Head of Clinical Departmentof Pathology, Biomedical Research Centre/Oxford University Hospitals Trust/University of Oxford, Senior Research Fellow, Kellogg College
- St Mungo Notman Professor and Chair, and Head of Pathology, University of Glasgow, Scientific Director, Glasgow Biomedicine Biorepository
- Professor and Chair, and Head of Department Department of Anatomical Pathology, School of Pathology and Laboratory Medicine, Nelson R Mandela Medical School, University of Natal & King Edward VIII Hospital, Durban, South Africa.
Publications: 418 papers in peer-reviewed, international journal articles. Several book chapters. Editor of Leong’s Manual of Immunohistology (4th edition).
Editor in Chief of Diagnostic Histopathology: 2010-2016
Editor in Chief of the Journal of Clinical Pathology: 2003-2009
Editor for Molecular Pathology/Reviews/Book reviews, Journal of Clinical Pathology: 2010-current Spoken at several international congresses and meeting.
- Vice Chancellor’s Research Award for 1997, University of Natal.
- Fellow of the University of Natal, December 1999.
- Mary Weston Achiever of the Year Award, November 1999, University of Natal.
- Best Teacher Award for Residents in Pathology, 2003-2004, University of Toronto.
- Individual Teaching Excellence Award, Wightman Berris Academy, 2006-2007, University of Toronto
Dr. Maher A. Sughayer
Director of KHCCBIO, Amman, Jordan
Dr. Maher A. Sughayer received his MD degree from Jordan University in 1983. He was trained in pathology at Deaconess hospital-Harvard Medical School in Boston, MA, and then at the Johns Hopkins Hospital in Baltimore, MD, USA. He is certified by the American Board of Pathology in 3 disciplines: Anatomic Pathology, Clinical Pathology and Cytopathology. He served as the Chair of Pathology at the Makassed Hospital in Jerusalem and was appointed as an associate professor of pathology at Al-Quds University, Jerusalem. Currently and since 2002 M. Sughayer is a full member and chair of pathology at King Hussein Cancer Center, Jordan. Dr. Sughayer established KHCCBIO a cancer biobank in Jordan in 2014. He has more than 55 peer-reviewed papers and 2 book chapters.
Ma’n H. Zawati
Executive Director of the Centre of Genomics and Policy and member of the University’s Biomedical Ethics Unit - McGill University, Montreal - Canada
Ma’n H. Zawati (LL.B., LL.M.) is a lawyer and the Executive Director of the Centre of Genomics and Policy at McGill University. He is also an Associate Member of the University’s Biomedical Ethics Unit since 2013. His research focuses on the legal and ethical aspects of biobanking as well as the legal duties and liability of health care professionals in both the clinical and research settings. He has published numerous articles on issues such as access to genomic databases, the return of research results/incidental findings, the legal liability of physicians and the closure of biobanks. Mr. Zawati has also presented on these topics in Canada and internationally.
Prof. Kurt Zatloukal
Chair of CBmed Center for Biomarker Research in Medicine. Graz, Austria
Kurt Zatloukal is professor of pathology at the Medical University of Graz, Austria. His research focusses on molecular pathology of diseases as well as biobanking and related data management technologies. He coordinated the preparatory phase of the European biobanking and biomolecular research infrastructure (BBMRI-ERIC) and is director of the Austrian national node BBMRI.at. He contributed to the development of new European standards and norms for pre-analytical processing of tissue samples for molecular testing He is Member of the Academia Europaea and has published 206 scientific papers and was co-inventor of 25 patent applications.
Dr Mohammed Ghaly
Professor at the Research Centre for Islamic Legislation & Ethics (CILE) College of Islamic Studies (CIS) Hamad Bin Khalifa University (HBKU), Qatar
Dr Mohammed Ghaly is professor of Islam and Biomedical Ethics at the research Centre for Islamic Legislation & Ethics (CILE), College of Islamic Studies (CIS) at Hamad Bin Khalifa University, Qatar. In 1999, he did Islamic Studies in English at Al-Azhar University in Cairo, Egypt and was awarded his Bachelor’s degree with cum laude. In 2002, he got his M.A. degree in Islamic Studies, also with cum laude, from Leiden University, the Netherlands and in 2008 he received his PhD from the same university.
During the period 2007-2013, Ghaly was a faculty member at Leiden University and since 2011 he has been a faculty member at the Erasmus Mundus Program; the European Master of Bioethics jointly organized by a number of European universities. Ghaly is the editor-in-chief of the Journal of Islamic Ethics (published by Brill) and serves on the editorial board of a number of academic journals. He is the research consultant of a number of research projects as well. He currently leads a large scale project on Genomics and Islamic Ethics (2016-2019), funded by the Qatar National Research Fund (QNRF). He was invited to lecture on Islamic bioethics at many universities worldwide including Imperial College London, Oxford University, University of Oslo, University of Chicago and Georgetown University. During the academic year 2014-2015, he was Visiting Researcher of the Kennedy Institute of Ethics at Georgetown University, USA.
Ms. Noor Al-Merekhi
Director of Programs at Qatar National Research Fund (QNRF)
Noor AL-Merekhi is the Director of Programs at Qatar National Research Fund (QNRF), she joined QNRF in 2007, and holds Executive Strategic MBA from HEC Paris 2016, and MSc in Human Genetics from Leeds University 2005. She was part of the development and start-up of QNRF’s flagship program NPRP, Exceptional Proposal, BRIO, and many research and capacity building programs, now she leads a team of program managers and officers in the development, facilitation and management of QNRF different funding programs during the pre-award phase, these programs include capacity building programs such as UREP, GSRA, and PDRA, research connection programs such as CWSP, and competitive research funding programs such as NPRP, JSREP, OSRA, PPM…etc. In 2011 she became a member for Qatar National Ethical Compliance Committee in Supreme Council of Health (SCH), and served in the implementation of the national ethical compliance policies as part of QNRF funding programs, she is also a member of the Global Research Council (GRC) and a MENA region representative.
Dr. Sameera Ezzat
Professor of Public Health, Chair of Epidemiology and Preventive Medicine Department, Director of NLI-SSI Collaborative Research Centre - National Liver Institute, Menoufia University - Egypt
Dr Samera Ezzat graduated from Faculty of Medicine, Cairo University in 1995.
She got her PhD/MD degree of Public Health in 2006 from Cairo University and her thesis was in collaboration with Georgetown University, USA. And she received raining at Johns Hopkins University, USA.
She is a Professor of Public Health, Chair of Epidemiology and Preventive Medicine Department, Director of NLI-SSI Collaborative Research Centre, National Liver Institute, Menoufia University.
She also served as a Director of Research at Children’s Cancer Hospital 57357-Egypt, from 2008-2014.
Dr Sameera has a lot of research studies in the areas of Epidemiology of cancer as well as gene-environment interactions and its relationship with cancer incidence.
Dr Sameera is a PI of many relevant grants. She worked in many grants funded by National and International agencies, such as US-NIH. She is PI of Genetic Epidemiology Centre of Excellence at the at Children’s Cancer Hospital 57357-Egypt.
She has 30 international publications and she was awarded the National Motivation Award in Medical Sciences in 2011.
Dr. Iman Gouda Farahat
National Cancer Institute, Cairo University, Egypt.
Iman Gouda Farahat is a Professor, Department of Pathology, National Cancer Institute, at Cairo University and Principal Investigator, Egyptian National Cancer Institute Biobank (Centers of Scientific Excellence Grant).
- Consultant and Director of Pathology Lab, Baheya Breast Cancer Centre, Egypt. 2015-present
- Consultant Pathologist, Children Cancer Hospital of Egypt. 2007- 2015
- Consultant and Director of Pathology Lab, Tanta Cancer Centre, Egypt. 2000-2005
- Associate Professor of Pathology, National Cancer Institute, Cairo University. 2009- 2015
- Lecturer of Pathology, National Cancer Institute, Cairo University. 2003 -2009
- Assistant Lecturer of Pathology, National Cancer Institute, Cairo University. 2003-2009
- Pathology Resident, National Cancer Institute, Cairo University. 1995-1998
You are being invited to take part in Qatar Biobank, Qatar’s long-term medical health initiative for Qatar’s population. To help you decide whether to contribute, here is some information on Qatar Biobank and what taking part involves.
Qatar Biobank will make it possible for scientists to conduct research to address some of the greatest health challenges facing Qatar and the region, including cardiovascular disease, obesity, diabetes, and cancer.